Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection

NCT06644417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

HBV Infection With LLV

Interventions

DRUG: TQA3605 tablets plus NAs
DRUG: TQA3605 Placebo plus NAs

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.